Development of Small Molecule Drugs for the Treatment of Liver Disease

Viral hepatitis is the most harmful of the different hepatitis and millions of people die from viral hepatitis infections every year. We offer comprehensive drug development services for the development of vaccines and antiviral drugs for viral hepatitis. Our antiviral drug development services cover types of small molecule drugs, natural compounds, and oligonucleotide drugs. By providing comprehensive drug development services, we are committed to facilitating the discovery of antiviral drugs.

Hydrogen therapy and boron neutron capture therapy are newly discovered therapeutic approaches. Since oxidative stress is an important pathological cause of the liver disease process, we have developed a well-established protocol that combines hydrogen therapy and liver disease treatment, which facilitates the study of the therapeutic efficacy of hydrogen therapy for liver disease. Our services include but are not limited to, preclinical evaluation of hydrogen therapy and screening of delivery pathways for hydrogen therapy. In contrast, boron neutron capture therapy has shown excellent results in the treatment of cancer. We provide in vitro and in vivo evaluation services for boron neutron capture therapy.